SynRG Becomes First Russian Member of European Forum for Good Clinical Practice

Wednesday, December 16, 2009 06:44 AM

Russia-based contract research organization (CRO) SynRG recently became the first Russian member of the European Forum for Good Clinical Practice (EFGCP), an organization created in 1993 to help develop and evaluate European health research. One of the EFGCP’s main purposes is to promote Good Clinical Practice (GCP) throughout Europe.

“We have a mutual interest in facilitating the conduct of clinical research projects in Russia to the highest standards of GCP, by providing appropriate information and training of investigators and ethics committees in these standards,” said Frank Wells, EFGCP’s Ethics Officer.

Through SynRG’s participation in the organization, EFGCP hopes to establish a dialogue with Russian non-profit and government institutions involved in clinical trials in Russia, as well as launch EFGCP training programs for Russia-based CRAs, investigators and members of the local ethics committees. SynRG hopes its participation in the organization will improve Russia’s clinical trial market and help the company attract foreign study sponsors.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 25

Verizon Communications enters clinical trial space with technology, network, and cloud and data services

Sponsors look to the power of genomic profiling to screen, enroll patients in trials for targeted therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs